K. Landolsi et al. / Journal of Organometallic Chemistry 690 (2005) 513–518
517
ligand); 43.55 and 49.61 (CH2 on ligand); 62.51 and
64.78 (C(6) and C(8), CH2 (allyl)); 120.57–143.18 (Caro
and C(7)-allyl); 151.08 (C–N on C6H5); 180.33 and
181.02 (C@N on ligand).
Yields, physical and spectral data of compounds 9–12
are reported below.
on ligand); 2.52 (s, 2H, H6anti and Ha8nti); 2.58 (s, 2H,
H6syn and H8syn); 2.85 (sept, 2H, CH-CH3, JHH = 6.9
Hz); 3.19 (sept, 2H, CH-CH3, JHH = 6.9 Hz); 4.17 (dd,
2H, J = 13.8 Hz, CH2 on ligand); 7.28 (s, 6H, Haro, Aro-
matic H of Ar group); 13C NMR ( 75.5 MHz, CD2Cl2,
25 ꢁC, d [ppm]): d = 22.28 (Me-allyl); 23.37 (Me on iPr
group); 23.58 (Me on iPr group); 23.78 (Me on iPr
group); 24.18 (Me on iPr group); 24.87 (Me on ligand);
28.34 (CH on iPr group); 28.73 (CH on iPr group); 48.20
(CH2 on ligand); 64.87 (C(6) and C(8), CH2 (allyl));
124.409 (p-C on C6H3); 127.37 (o-C on C6H3); 137.04
(m-C on C6H3);137.38 (m0-C on C6H3); 138.35 (C7(al-
lyl)); 147.62 (C–N); 177.08 (C@N on ligand).
4.2.2. [(oꢀCH3-C6H4NC(Me)CH 2C(Me)NC6H4-o-CH 3)-
Pd(g3-C4H7)]þPF 6ꢀ (9)
Yield = 89%. C23H29N2PF6Pd. (584.88): Calc. C,
47.230; H, 5.101; N, 4.790. Found: C, 47.247; H,
5.303; N, 4.139%. IR (Golden Gate): mC@N = 1660
1
cmꢀ1. H NMR (300 MHz, CD2Cl2, 25 ꢁC, d [ppm]):
d = 1.74 (s, 3H, Me (allyl)); 1.98–2.24 (m, 12H, Me on
ligand and o-CH3 on C6H4); 2.48 (s, 2H,
Ha6nti and H8anti); 2.53 (s, 2H, H6syn and H8syn); 3.88–4.11
(m, 2H, ligand-CH2); 6.84–7.18 (m, 8H, ArH). 13C
NMR (75.5 MHz, CD2Cl2, 25 ꢁC, d [ppm]): d = 18.21–
18.55 (Me (allyl)); 23.18 and 24.15 (Me on ligand);
24.36 and 24.46 (o-C on C6H4); 49.73 and 50.12 (CH2
on ligand); 63.55 and 64.66 (C(6) and C(8), CH2 (allyl));
120.51 and 120.84 (p-C on C6H4); 127.35–129.71 (o0-C
and o0-C on C6H4); 131.87–132.06 (m-C and m0-C on
C6H4); 137.33 and 137.79 (C(7)-allyl); 151.02 and
151.67 (C–N on C6H4); 177.07 and 177.21 (C@N on
ligand).
4.2.5. [(2,6-(iPr)2-C6H3NC(Me)CH2C(Me)NC6H3-2,
6-(iPr)2)Pd(g3-C4H7)]+ [B(3,5-(CF3)2C6H3)4]ꢀ (12)
Yield = 91%. C33H49N2Pd Æ BC32H12F24 Æ CH2Cl2
(1528.34): Calc. C, 51.87; H, 4.15; N, 1.83. Found: C,
51.37; H, 3.861; N, 1.88%. IR (Golden Gate):
1
m
C@N = 1663 cmꢀ1). H NMR (300 MHz, CD2Cl2, 25
ꢁC, d [ppm]): d = 1.05 (d, 6H, JHH = 3.3 Hz, CH(CH3)2);
1.10 (d, 6H, JHH = 3.6 Hz, CH(CH3)2); 1.20 (d, 6H,
JHH = 3.3 Hz, CH(CH3)2); 1.25 (d, 6H, JHH = 3.6 Hz,
CH(CH3)2); 1.84 (s, 3H, Me-allyl); 1.96 (s, 6H, CH3
on ligand); 2.48 (s, 2H, H6anti and Ha8nti); 2.52 (s, 2H,
H6syn and H8syn); 2.71 (sept, 2H, CH-CH3, JHH = 3.9
Hz); 3.06 (sept, 2H, CH-CH3, JHH = 3.9 Hz); 3.97 (s,
2H, CH2 on ligand); 7.20–7.64 (s, 6H, Haro, Aromatic
H of Ar group). 13C NMR ( 75.5 MHz, CD2Cl2, 25
ꢁC, d [ppm]): d = 23.02 (Me-allyl); 23.37 (Me on iPr
group); 23.58 (Me on iPr group); 23.78 (Me on iPr
group); 24.18 (Me on iPr group); 24.87 (Me on ligand);
28.34 (CH on iPr group); 28.73 (CH on iPr group); 49.19
(CH2 on ligand); 66.10 (C(6) and C(8), CH2 (allyl));
125.39 and 125.49 (p-C on C6H3); 127.17 (o-C on
C6H3); 137.37 (m-C on C6H3);137.70 (m0-C on C6H3);
139.71 (C7(allyl)); 147.86 (C–N); 176.33 (C@N on lig-
4.2.3. [(2;6-CH3)2-C6H3NC(Me)CH2C(Me)NC6H3-2;6-
(CH3)2)Pd(g3-C4H7)]þPF ꢀ6 (10)
Yield = 92%. C25H33N2PF6Pd. (612.93): Calc. C,
48.880; H, 5.430; N, 4.570. Found: C, 49.140; H,
5.100; N, 4.847%. IR (Golden Gate): mC@N = 1667
1
cmꢀ1. H NMR (300 MHz, CD2Cl2, 25 ꢁC, d [ppm]):
d = 1.91 (s, 3H, H9, Me (allyl); 2.02 (s, 6H, o-CH3);
2.18 (s, 6H, o0-CH3); 2.28 (s, 2H, H6anti and Ha8nti); 2.31
(s, 6H, Me on ligand); 2.57 (s, 2H, H6syn and Hs8yn); 4.3
(dd, 2H, J = 13.8 Hz, CH2 on ligand); 7.07–7.118 (s,
6H, Haro). 13C NMR ( 75.5 MHz, CD2Cl2, 25 ꢁC, d
[ppm]): d = 17.86 (Me (allyl)); 18.06 (Me on ligand);
22.49 (o-Me on C6H3); 23.106 (o0-Me on C6H3); 48.11
(CH2 on ligand); 63.86 (C(6) and C(8), CH2 (allyl));
126.32 (p-C on C6H3); 126.49 (o-C on C6H3); 126.91
(o0-C on C6H2); 128.78 (m-C on C6H3); 129.93 (m0-C
on C6H3); 137.26 (C(7)-allyl); 150.16 (C–N on C6H3);
176.30 (C@N on ligand).
and) Æ [B(3,5-(CF3)2-C6H3)4]ꢀ:
118.17–119.94
127.161 (q, JCF = 104.9 Hz, CF3); 129.39 (q,
(Cp);
1
1JCF = 32.52 Hz, CF3); 161.5 (q, JCB = 49.8 Hz, Cipso).
19F NMR (282 MHz, CD2Cl2): d (referenced to external
C6F6) 63.27 (s, CF3).
1
4.3. X-ray crystallographic study
The X-ray crystallographic study of complex 12 was
carried out on an Enraf–Nonius Kappa CCD diffrac-
tometer (Mo Ka). Data were collected at 110 K for a
range of h up to 27.5ꢁ and this, gave a total of 25,131
4.2.4. [(2; 6-(iPr)2-C6H3NC(Me)CH2C(Me)NC6H3-2; 6-
(iPr)2)Pd(g3-C4H7)]þPF ꢀ6 (11)
Yield = 94%; C33H49N2PF6Pd. (725.15): Calc. C,
54.660; H, 6.810; N, 3.861. Found: C, 54.699; H,
6.471; N, 4.021%. IR (Golden Gate): mC@N = 1663 and
reflections, yielding 15,208 independent values (Rint
=
0.0612). The structure was solved by direct method
and difference Fourier techniques and were refined by
full-matrix last-squares analysis. Refinements were
based on F2 and were carried out using all the data
(SHELXL-97). All of the non-hydrogen atoms were re-
fined anisotropically. One CF3 group of the anion was
1640 cmꢀ1
.
1H NMR (300 MHz, CD2Cl2, 25 ꢁC, d
[ppm]): d = 1.2 (d, 6H, JHH = 6.9 Hz, CH(CH3)2); 1.23
(d, 6H, JHH = 6.9 Hz, CH(CH3)2); 1.32 (d, 6H,
JHH = 6.6Hz, CH(CH3)2); 1.36 (d, 6H, JHH = 6.9 Hz,
CH(CH3)2); 1.94 (s, 3H, Me-allyl); 2.11 (s, 6H, CH3